Amgen Inc.

156.12 +0.76(0.49%) Date:

Amgen Inc.

Amgen, Inc. (AMGN): Jefferies Update from Amgen Analyst Event

Jefferies provides its key takeaways from Amgen analyst event

Amgen, Inc. (NASDAQ:AMGN) Amgen Wins Permanent Injunction Against Praluent

Baird thinks a hefty settlement is likely, possibly to the tune of 20%+ royalties to Amgen

Will Pfizer Inc. (NYSE:PFE) and Amgen, Inc. (NASDAQ:AMGN) Survive the Biosimilar Impact in 2017?

The drugmakers will have to sort out new ways to slow down the biosimilar growth

Amgen, Inc. (NASDAQ:AMGN) Moving Ahead in European Therapeutic Markets

The company has an exceptional opportunity to establish its presence in the European Union

Amgen, Inc. (NASDAQ:AMGN) Stock's Two-Year Low Offers Buying Opportunity: Argus

Argus analysts believe Amgen stock is oversold after the drop on the back of its third quarter earnings release